CD27low natural killer cells prolong allograft survival in Mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner

Transplantation

Volumn 99, Issue 2, 2015, Pages 391-399

  Lantow, Margareta ^a   Eggenhofer, Elke ^a   Sabet Baktach, Manije ^a   Renner, Philipp ^a   Rovira, Jordi ^a   Koehl, Gudrun E ^a   Schlitt, Hans J ^a   Geissler, Edward K ^a   Kroemer, Alexander ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; GAMMA INTERFERON; RAG1 PROTEIN; TRANSCRIPTION FACTOR T BET; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL HETEROGENEITY; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHARMACOLOGICAL BLOCKING; SKIN GRAFT; T LYMPHOCYTE SUBPOPULATION; ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; DEFICIENCY; GENETICS; GENOTYPE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PHENOTYPE; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; TIME; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD27; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HOMEODOMAIN PROTEINS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; T-BOX DOMAIN PROTEINS; TIME FACTORS;

EID: 84922873801     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000585     Document Type: Article

References (28)

1. Maier S, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001;7(5):557.
2. McNerney ME, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006;6(3):505.
3. Uehara S, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005;175(5):3424.
4. Yu G, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006;203:1851.
5. Kroemer A, et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008;180(12):7818.
6. Beilke JN, et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005;11(10):1059.
7. van der Touw W, et al. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. Transplantation 2012; 94(6):575.
8. Habiro K, et al. Effect of inflammation on costimulation blockade-resistant allograft rejection. Am J Transplant 2005;5(4 Pt 1):702.
9. Yuan X, et al. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J ExpMed 2008;205(13):3133.
10. Zecher D, et al. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells. J Immunol 2010;184(12):6649.
11. Laffont S, et al. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008;112(3):661.
12. Kroemer A, Edtinger K, Li XC. The innate natural killer cells in transplant rejection and tolerance induction. Curr Opin Organ Transplant 2008; 13(4):339.
13. Hayakawa Y, et al. Functional subsets of mouse natural killer cells. Immunol Rev 2006;214:47.
14. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176(3):1517.
15. Huntington ND, Vosshenrich CA, Di Santo JP. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007;7(9):703.
16. Sabet-Baktach M, et al. Double deficiency for RORgammat and T-bet drives Th2-mediated allograft rejection in mice. J Immunol 2013; 191(8):4440.
17. Vivier E, et al. Functions of natural killer cells. Nat Immunol 2008;9(5):503.
18. Daussy C, et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J Exp Med 2014;211:563.
19. Gordon SM, et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012;36(1):55.
20. Robbins SH, et al. Direct effects of T-bet and MHC class I expression, but not STAT1, on peripheral NK cell maturation. Eur J Immunol 2005; 35(3):757.
21. Townsend MJ, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKTcells. Immunity 2004;20(4):477.
22. Rovira J, et al. A color-coded reporter model to study the effect of immunosuppressants on CD8+ T-cell memory in antitumor and alloimmune responses. Transplantation 2013;95(1):54.
23. Kim J, et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol 2007; 179(10):6416.
24. Moreland L, Bate G, Kirkpatrick P. Abatacept. Nat Rev Drug Discov 2006;5(3):185.
25. Ford ML, Adams AB, Pearson TC. Targeting co-stimulatory pathways: transplantation and autoimmunity. Nat Rev Nephrol 2014;10(1):14.
26. Yuan X, et al. Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci U S A 2009; 106(26):10734.
27. Burrell BE, et al. CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008;181(6):3906.
28. Malaise M, et al. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma. J Immunol 2014;192(4):1954.